BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22192801)

  • 1. Matrix-assisted laser desorption/ionization mass spectrometry reveals decreased calcylcin expression in small cell lung cancer.
    Lee HS; Park JW; Chertov O; Colantonio S; Simpson JT; Fivash MJ; Yoo CW; Lee GK; Zo JI; Kim HT; Kim HK
    Pathol Int; 2012 Jan; 62(1):28-35. PubMed ID: 22192801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid MALDI profile classifies non-small cell lung cancers according to the histologic type.
    Lee GK; Lee HS; Park YS; Lee JH; Lee SC; Lee JH; Lee SJ; Shanta SR; Park HM; Kim HR; Kim IH; Kim YH; Zo JI; Kim KP; Kim HK
    Lung Cancer; 2012 May; 76(2):197-203. PubMed ID: 22099218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histology-directed matrix-assisted laser desorption/ionization analysis reveals tissue origin and p53 status of primary liver cancers.
    Jeon YE; Lee SC; Paik SS; Lee KG; Jin SY; Kim HR; Yoo CW; Park HM; Han SY; Choi DH; Kim HK
    Pathol Int; 2011 Aug; 61(8):449-55. PubMed ID: 21790858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen biomarkers for early diagnosis of lung adenocarcinoma].
    Tian YX; Yang SY; Nan YD; Zhang W; Yu JK; Zheng S
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):157-61. PubMed ID: 19292069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliable Entity Subtyping in Non-small Cell Lung Cancer by Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry on Formalin-fixed Paraffin-embedded Tissue Specimens.
    Kriegsmann M; Casadonte R; Kriegsmann J; Dienemann H; Schirmacher P; Hendrik Kobarg J; Schwamborn K; Stenzinger A; Warth A; Weichert W
    Mol Cell Proteomics; 2016 Oct; 15(10):3081-3089. PubMed ID: 27473201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.
    Shevchenko VE; Arnotskaya NE; Zaridze DG
    Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein and lipid MALDI profiles classify breast cancers according to the intrinsic subtype.
    Kang HS; Lee SC; Park YS; Jeon YE; Lee JH; Jung SY; Park IH; Jang SH; Park HM; Yoo CW; Park SH; Han SY; Kim KP; Kim YH; Ro J; Kim HK
    BMC Cancer; 2011 Oct; 11():465. PubMed ID: 22029885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.
    Yanagisawa K; Tomida S; Shimada Y; Yatabe Y; Mitsudomi T; Takahashi T
    J Natl Cancer Inst; 2007 Jun; 99(11):858-67. PubMed ID: 17551146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid profiles for intrahepatic cholangiocarcinoma identified using matrix-assisted laser desorption/ionization mass spectrometry.
    Park YS; Yoo CW; Lee SC; Park SJ; Oh JH; Yoo BC; Paik SS; Lee KG; Jin SY; Kim SC; Kim KP; Kim YH; Choi D; Kim HK
    Clin Chim Acta; 2011 Oct; 412(21-22):1978-82. PubMed ID: 21777572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration in lipid and protein profiles of ovarian cancer: similarity to breast cancer.
    Kang S; Lee A; Park YS; Lee SC; Park SY; Han SY; Kim KP; Kim YH; Yoo CW; Kim HK
    Int J Gynecol Cancer; 2011 Dec; 21(9):1566-72. PubMed ID: 22123712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of lung adenocarcinoma using magnetic beads based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry serum protein profiling.
    Lin XL; Yang SY; Du J; Tian YX; Bu LN; Huo SF; Wang FP; Nan YD
    Chin Med J (Engl); 2010 Jan; 123(1):34-9. PubMed ID: 20137572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
    Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic profiling in musculoskeletal oncology by MALDI mass spectrometry.
    Holt GE; Schwartz HS; Caldwell RL
    Clin Orthop Relat Res; 2006 Sep; 450():105-10. PubMed ID: 16906088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics-based identification of tumor relevant proteins in lung adenocarcinoma.
    Zhou X; Xue L; Hao L; Liu S; Zhou F; Xiong H; Qi X; Lin D; Shao S
    Biomed Pharmacother; 2013 Sep; 67(7):621-7. PubMed ID: 23916545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MALDI-ToF mass spectrometry for the rapid diagnosis of cancerous lung nodules.
    Brégeon F; Brioude G; De Dominicis F; Atieh T; D'Journo XB; Flaudrops C; Rolain JM; Raoult D; Thomas PA
    PLoS One; 2014; 9(5):e97511. PubMed ID: 24830707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of serum surface-enhanced laser desorption/ionization proteomic patterns in distinguishing non-small cell lung cancer patients from healthy people].
    Yang SY; Xiao XY; Zhang WG; Sun XZ; Zhang LJ; Zhang W; Zhou B; Yang DC; He DC
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jan; 29(1):31-4. PubMed ID: 16638298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS.
    Sanders ME; Dias EC; Xu BJ; Mobley JA; Billheimer D; Roder H; Grigorieva J; Dowsett M; Arteaga CL; Caprioli RM
    J Proteome Res; 2008 Apr; 7(4):1500-7. PubMed ID: 18386930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes.
    Jacot W; Lhermitte L; Dossat N; Pujol JL; Molinari N; Daurès JP; Maudelonde T; Mangé A; Solassol J
    J Thorac Oncol; 2008 Aug; 3(8):840-50. PubMed ID: 18670301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.
    Yildiz PB; Shyr Y; Rahman JS; Wardwell NR; Zimmerman LJ; Shakhtour B; Gray WH; Chen S; Li M; Roder H; Liebler DC; Bigbee WL; Siegfried JM; Weissfeld JL; Gonzalez AL; Ninan M; Johnson DH; Carbone DP; Caprioli RM; Massion PP
    J Thorac Oncol; 2007 Oct; 2(10):893-901. PubMed ID: 17909350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.